Agenda for Day 2 – Wednesday, March 24, 2027 - EST/EDT (Eastern Daylight, GMT-4)
Move beyond the traditional "insource vs. outsource vs. hybrid" hub model framework and explore the reality most manufacturers face: managing a complex ecosystem that includes internal capabilities alongside multiple vendors with overlapping and specialized functions
Evaluate the strategic trade-offs between consolidation and specialization to understand the benefits and drawbacks of working with a few full-service partners versus diversifying across best-of-breed vendors for specific functions
Benchmark on when it is best to consolidate for efficiency and control, when to specialize for expertise and performance and how to balance risk across your partner portfolio
Understand that partner strategy is not a one-time decision: explore how to approach the initial selection of your hub partner ecosystem, and how to maintain, optimize and evolve those relationships over time as your business needs, product portfolio and market dynamics shift
- Mary Lynn Kelley - President of Patient Services, eMAX Health Patient Services
- MacKenzie McConville - Director, Patient Services Program Strategy, Alexion Pharmaceuticals, Inc.
- Rhonda Hughes - Vice President, Head of Patient Services, Biogen
Navigate the full vendor lifecycle from selection through continuous improvement and learn best practices for running effective RFPs, onboarding new partners and preparing for launch with clear expectations and aligned success metrics
Understand the critical “hyper care" period after launch and discover how to work collaboratively with vendors to rapidly optimize program performance and address real-time challenges
Hear what manufacturers are really seeking from vendor partnerships, including more access to operational teams, transparent case studies with specific examples and honest conversations about what's realistic
Develop a framework for evaluating vendor capabilities, fostering accountability and building long-term partnerships that drive procces excellence and measurable program outcomes
- Joanne de Vries - Vice President & Head of Patient Services, Rare Blood Disorders & Oncology, Sanofi
- Suzanne Pawlicki - Chief Operating Officer, Pro-Spectus
Understand how to assess the viability of patient support programs and learn best practices to not only measure program impact but also build the business case needed to secure organizational buy-in and continued funding
Navigate the constant tension manufacturers face between doing right by the patient and managing internal pressure around high, fixed costs
Explore the balance between business profitability and patient access to determine what you can realistically afford to invest in for patient support
Learn how GTN (gross-to-net) dynamics fit into the broader income story and how patient support programs impact your bottom line
Identify which initiatives deliver measurable value, where to optimize spending without compromising the patient journey and how to champion patient support investments with cross-functional alignment from finance, commercial and market access teams
- Amy Brown - CEO and Founder, Authenticx
Explore strategies for scaling FRM teams effectively as programs expand, including optimal deployment methods tailored to specific product and market needs
Assess when in a product's lifecycle it makes sense to invest in field reimbursement resources, including the ongoing debate around scaling down or sunsetting FRM teams post-launch
Navigate operational and compliance guardrails to highlight where FRMs can be more innovative
Discover how successful field reimbursement managers are collaborating with sales and other key stakeholders
Explore best practices for how patient support, hubs, sales, and centralized operations can effectively work with field teams to ensure seamless handoffs and support patients through the full treatment journey
- Rose Kozar - Field Access Market Strategy Lead, Courier Health
- Tarek El Ali, MPH, MBA - Associate Director, Reimbursement Strategy, AbbVie
- Develop strategies in expanding hub models to meet increasing demand while maintaining seamless patient and provider experiences
Ensure consistency and quality across programs as operations grow in scale and complexity
Learn from real-world examples of organizations that successfully scaled their hub operations without disrupting patient or provider support
Establish best practices for managing vendor partnerships to ensure alignment, accountability and operational excellence
- Examine the patient access timeline, from benefit investigation through appeals, and identify where patients are most likely to drop off therapy during the insurance journey
Understand turnaround time benchmarks for benefit verification and prior authorization across payer types, and learn which insurers create the most friction in access workflows
Explore the data transparency gap: why specialty pharmacies often withhold payer-level insights from manufacturers, how this limits your ability to assess contract performance and strategies to gain better visibility into patient insurance experiences
Discover how digital tools like eBV and EHR/EMR integration can compress timelines, reduce manual touchpoints and keep patients engaged through adherence, persistence and continuation milestones
Explore the operational models available for structuring hub and patient support teams, from centralized approaches to more siloed structures
Understand the challenges and opportunities associated with each structure, and evaluate which model is the best fit for your organization based on strategic priorities, team capabilities and cross-functional dependencies
Assess how to design efficient and effective teams within your chosen model: evaluate tiered approaches, role assignments and span of control to determine the right structure and identify emerging roles that bridge gaps
Examine the leadership skills required to drive execution and accountability across different organizational models
- Explore enforcement risks facing patient support services and hub models from government and industry perspectives
Understand how investigations take shape and which conduct and compliance gaps attract scrutiny
Discuss examples of recent enforcement actions and what they reveal about government priorities and strategy
Explore how regulatory proceedings develop – and how companies can respond as legal, operational, and reputational risks converge
Understand why retail pharmacies are increasingly rejecting specialty-lite products, especially low-volume brands, and why even borderline specialty launches now require specialty pharmacy infrastructure to succeed
Explore what "hub-lite" means in practice: determine the right level of support for your product, evaluate distribution strategies and assess cost-benefit tradeoffs when full hub infrastructure may not be justified
Learn how specialty pharmacies absorb traditional hub functions like benefit verification and patient program navigation, and identify which activities still require dedicated hub resources versus what SPs can handle independently
- Meghan Hover - Senior Director, Patient Services, Ardelyx, Inc.
Explore how inconsistencies at the point of entry, whether through providers, specialty pharmacies or support programs, create friction that can prevent successful patient enrollment
Identify the root causes of unreliable patient capture, even when infrastructure and standard processes are in place, and understand where handoffs, timing mismatches or workflow gaps are causing drop-off
Learn how enrollment tools and technology can create frictionless, point-of-care experiences by synchronizing workflows, reducing administrative burden and meeting patients at the right moment in their journey
Approach patient acquisition as a strategic design problem rather than an operational afterthought, and apply human-centered design principles to build enrollment pathways that deliver predictable, repeatable results
